Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Concludes Integration of Acquired Biosimilars Business in 120 countries; 10+ Emerging Markets, Japan & ANZ Transition in Final Phase'. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.